§ 01 Overview
Overview
Autophagy-inducing peptide that enhances Beclin-1 activity, studied for neurodegeneration and infection in preclinical models.
Published preclinical work; no human trials.
§ 02 Mechanism
Mechanism of action
Tat-Beclin-1 is a cell-penetrating peptide fused to a region of Beclin-1. It competes with GAPR-1 to free Beclin-1, enhancing autophagy initiation.
- 01Autophagy induction in preclinical models
- 02Potential neuroprotective effects
§ 03 Dosing
Dosing protocol
Standard Protocol
- Dose Range
- Not characterized
- Route
- SubQ
- Frequency
- Research protocols
§ 04 Evidence
Evidence & research
Published preclinical work; no human trials.
FDA Status
Not FDA-approved.
§ 07 Sourcing
Sourcing & supply
Regulatory status
Research-only, no commercial channel
No commercial channel exists. Available only as a research reagent from RUO suppliers. Use in humans is not established.
No suppliers in our directory currently stock this compound. For investigational or research-only compounds, legitimate channels may not exist outside clinical trials.
Browse full supplier directory§ 09 Safety
Safety & side effects
Side effects
- 01Unknown in humans
Contraindications
None specified.